Additionally, in human myeloid malignancies, including AML, chronic myeloid leukemia, and particularly mast cell leukemia, the leukemia-initiating cells are considered to occupy the CD34-positive subpopulation of the malignant clone [33–35]. This evidence concerns the gene CD34 and myeloid neoplasm.